美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Korsana Biosciences Inc

32.08

+0.47001.49%

盤後：32.080.00000.00%19:56 EDT

成交量：11.89萬

成交額：378.82萬

市值：14.60億

市盈率：-2.73

高：35.33

開：30.44

低：30.44

收：31.61

52周最高：59.36

52周最低：7.19

股本：4,550.00萬

流通股本：4,504.23萬

量比：2.05

換手率：0.26%

股息：- -

股息率：- -

每股收益(TTM):-11.7644

每股收益(LYR):-7.7700

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):-4.13

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Korsana Biosciences Inc

交易所：

NASDAQ

成立時間：

2024

員工人數：

- -

公司地址：

221 Crescent Street,Building 23,Suite 105,Waltham,Massachusetts,United States

官網：

http://www.korsana.com

郵編：

02453

電話：

傳真：

- -

簡介：

Korsana Biosciences, Inc.於2018年9月6日在馬薩諸塞州聯邦註冊成立。Korsana Biosciences的成立是為了減輕患者和護理人員的神經退行性疾病負擔。與Paragon Therapeutics合作開發的Therapeutic Targeting是一種新型的血腦屏障穿透式穿梭平台，旨在實現大腦內部顯著更高的藥物濃度，並克服早期穿梭技術的限制。Korsana正在推進一系列針對神經退行性疾病的創新THETA療法，首先是用於治療阿爾茨海默病的KRSA-028。

董事

名稱

職位

Jonathan Violin

Chief Executive Officer and Director and President

Andrew Gottesdiener

Director

Heidi Henson

Director

Michelle Pernice

Director

Nimish Shah

Director

Tomas Kiselak

Director

股東

名稱

職位

Jonathan Violin

Chief Executive Officer and Director and President

Mark Vignola

Chief Financial Officer

Madelyn Zeylikman

General Counsel and Secretary

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/KRSA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"KRSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRSA\",,,,,undefined,":{"symbol":"KRSA","market":"US","secType":"STK","nameCN":"Korsana Biosciences Inc","latestPrice":32.08,"timestamp":1789502400000,"preClose":31.61,"halted":0,"volume":118943,"hourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":32.08,"latestTime":"19:56 EDT","volume":32,"amount":1004.825,"timestamp":1789516570449,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014868712432774402,"floatShares":45042270,"shares":45500000,"eps":-11.7644,"marketStatus":"未開盤","change":0.47,"latestTime":"09-15 16:00:00 EDT","open":30.44,"high":35.325,"low":30.44,"amount":3788153.518754,"amplitude":0.15454,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.7644,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":31.61,"preHourTrading":{"tag":"盘前","latestPrice":31.61,"preClose":31.61,"latestTime":"08:18 EDT","volume":13,"amount":410.93,"timestamp":1789474698078,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":32.08,"preClose":32.08,"latestTime":"19:56 EDT","volume":32,"amount":1004.825,"timestamp":1789516570449,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.050409},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KRSA\",,,,,undefined,":{"symbol":"KRSA","floatShares":45042270,"roa":"--","roe":"--","lyrEps":-7.77,"volumeRatio":2.050409,"shares":45500000,"dividePrice":0,"high":35.325,"amplitude":0.15454,"preClose":31.61,"low":30.44,"week52Low":7.1862,"pbRate":"--","week52High":59.36,"institutionHeld":0,"latestPrice":32.08,"eps":-11.7644,"divideRate":0,"volume":118943,"delay":0,"ttmEps":-11.7644,"open":30.44,"prevYearClose":8.89,"prevWeekClose":31.905,"prevMonthClose":25.76,"prevQuarterClose":23.73,"fiveDayClose":23.52,"twentyDayClose":28.21,"sixtyDayClose":22.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KRSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-09","symbol":"KRSA","defaultRemindTime":1788960600000,"type":"split","dateTimestamp":1788926400000,"forFactor":7,"toFactor":1,"ratio":7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KRSA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KRSA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1789444800000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1966002000,"yearFounded":2024,"address":"221 Crescent Street,Building 23,Suite 105,Waltham,Massachusetts,United States","zipCode":"02453","officePhone":"(781) 516-2325"},"stockCompanyDetail":{"websiteUrl":"http://www.korsana.com","stockEarnings":[{"period":"1week","weight":0.0625},{"period":"1month","weight":0.1915},{"period":"3month","weight":0.42},{"period":"6month","weight":2.093},{"period":"1year","weight":0.8357},{"period":"ytd","weight":2.5557}],"compareEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.0141},{"period":"6month","weight":0.1504},{"period":"1year","weight":0.1574},{"period":"ytd","weight":0.1158}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Korsana Biosciences, Inc.於2018年9月6日在馬薩諸塞州聯邦註冊成立。Korsana Biosciences的成立是為了減輕患者和護理人員的神經退行性疾病負擔。與Paragon Therapeutics合作開發的Therapeutic Targeting是一種新型的血腦屏障穿透式穿梭平台，旨在實現大腦內部顯著更高的藥物濃度，並克服早期穿梭技術的限制。Korsana正在推進一系列針對神經退行性疾病的創新THETA療法，首先是用於治療阿爾茨海默病的KRSA-028。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.030269},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.005726},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.111354},{"month":4,"riseRate":0.428571,"avgChangeRate":0.134458},{"month":5,"riseRate":0.25,"avgChangeRate":-0.02829},{"month":6,"riseRate":0.5,"avgChangeRate":0.038893},{"month":7,"riseRate":0.375,"avgChangeRate":0.026358},{"month":8,"riseRate":0.625,"avgChangeRate":0.100342},{"month":9,"riseRate":0.375,"avgChangeRate":0.010286},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.324291},{"month":11,"riseRate":0.285714,"avgChangeRate":0.0186},{"month":12,"riseRate":0.428571,"avgChangeRate":0.106805}],"exchange":"NASDAQ","name":"Korsana Biosciences Inc","nameEN":"Korsana Biosciences Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"KRSA\",market:\"US\",,,undefined,":{"directors":[{"name":"Jonathan Violin","position":"Chief Executive Officer and Director and President"},{"name":"Andrew Gottesdiener","position":"Director"},{"name":"Heidi Henson","position":"Director"},{"name":"Michelle Pernice","position":"Director"},{"name":"Nimish Shah","position":"Director"},{"name":"Tomas Kiselak","position":"Director"}],"executives":[{"name":"Jonathan Violin","position":"Chief Executive Officer and Director and President"},{"name":"Mark Vignola","position":"Chief Financial Officer"},{"name":"Madelyn Zeylikman","position":"General Counsel and Secretary"}]}}}